Clinical Trial

Dinalbuphine Sebacate in Postoperative Pain Control After TKA

Name: Dinalbuphine Sebacate in Postoperative Pain Control After TKA — clinical trial record (NCT07140510)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Naldebain

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Record status

This record was last updated August 24, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the effectiveness of Dinalbuphine Sebacate for controlling subacute pain after total knee arthroplasty

Trial Details

NCT Number	NCT07140510
Lead Sponsor	Thammasat University
Conditions	Osteo Arthritis of the Knee, Total Knee Anthroplasty
Enrollment	100 participants
Start Date	2025-10
Primary Completion	2026-06 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2025-08-24